Related Experiment Videos
Selective messenger RNA reduction in Alzheimer's disease
D R McLachlan1, W J Lukiw, L Wong
1Department of Physiology, University of Toronto, Canada.
Brain Research
|June 1, 1988
Summary
Alzheimer's disease significantly reduces neurofilament light (NF-L) mRNA in the brain. This specific mRNA decrease suggests a functional gene expression deficit, potentially impacting neuronal health and cytoskeleton integrity in Alzheimer's patients.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline.
- Cytoskeletal abnormalities, including abnormal filamentous components, are hallmarks of AD pathology.
- Neurofilament proteins are crucial components of the neuronal cytoskeleton.
Purpose of the Study:
- To investigate the relative abundance of specific messenger RNAs (mRNAs) in the neocortex of Alzheimer's disease patients compared to controls.
- To specifically examine the levels of mRNA coding for neurofilament light (NF-L) protein, a key component of neurofilaments.
- To explore potential mechanisms underlying observed mRNA level changes in AD.
Main Methods:
- Extraction and analysis of 7 different mRNAs from neocortex samples of Alzheimer's and control brains.
- Utilized Northern and quantitative dot blot analysis to determine mRNA abundance.
- Quantified mRNA levels as a percentage of total RNA and per gram of neocortex tissue.
Main Results:
- The mRNA for NF-L (neurofilament light) was significantly reduced in Alzheimer's disease neocortex, representing only 27% of control levels relative to total RNA, or 14% per gram of tissue.
- Six other examined mRNAs showed varied responses: some were significantly reduced to approximately 65% of control levels, while others showed no significant reduction.
- The substantial decrease in NF-L mRNA could not be explained by general factors like brain damage, neuron loss, or neurofibrillary degeneration.
Conclusions:
- The specific and significant reduction of NF-L mRNA in Alzheimer's disease suggests a functional deficit in gene expression, not merely a consequence of neuronal loss or damage.
- This deficit in NF-L mRNA may be linked to increased chromatin compaction, potentially impairing gene transcription.
- The inability of neurons to maintain adequate NF-L mRNA levels might contribute to the accumulation of abnormal filamentous proteins and the characteristic cytoskeleton pathology observed in Alzheimer's disease.